•  
  •  
  •  
  •  

2025-12-02 15:11:33

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Mazda Ltd receives order of Rs. 24.50 crore
  • Modison Limited declares interim dividend of Rs. 2.50
  • Websol signs MoU with Linton to explore PV ingot and wafer manufacturing in India
  • Tata Elxsi, University of Illinois Urbana-Champaign, and OSF HealthCare Partner to Transform Rural Healthcare Access in the United States
  • SPARC announces the U.S. District Court Grants Summary Judgement in Favour of SPARC for Sezaby PRV

Keywords Selected:  ShreeGaneshBiotechIndia

Stock Report

  • Shree Ganesh Biotech India Ltd Q2 FY2022-23 profit at Rs. 1.20 crore
  • Shree Ganesh Biotech India Ltd Q1FY23 net profit at Rs. 1.03 crore
  • Shree Ganesh Biotech India Ltd Q4 FY2022 profit jumps to Rs. 1.04 crore
  • Shree Ganesh Biotech India fixes April 28, 2022 as record date for bonus issue
  • Shree Ganesh Biotech India Ltd recommends 1:1 bonus issue
  • Shree Ganesh Biotech India Q3FY22 net profit climbs to Rs. 95.01 lakhs
  • Shree Ganesh Biotech India fixes Feb 11, 2022 as record date for stock split
  • Shree Ganesh Biotech India Ltd fixes Feb 11, 2022 as record date for stock split
  • Shree Ganesh Biotech India Ltd board recommends stock split
  • Shree Ganesh Biotech India Ltd board to consider stock split

Latest Post

  • Mazda Ltd receives order of Rs. 24.50 crore
  • Modison Limited declares interim dividend of Rs. 2.50
  • Websol signs MoU with Linton to explore PV ingot and wafer manufacturing in India
  • Tata Elxsi, University of Illinois Urbana-Champaign, and OSF HealthCare Partner to Transform Rural Healthcare Access in the United States
  • SPARC announces the U.S. District Court Grants Summary Judgement in Favour of SPARC for Sezaby PRV


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024